Also, the level of circulating visfatin is significantly lower in the fetus than in the mother during normal, PE, or IUGR pregnancies, which is in agreement with our results on the differences in visfatin protein expression between the maternal and fetal parts of the mentioned disorders. This evidence concerns the gene NAMPT and fetal growth restriction.